Drug intelligence / Profile preview

live attenuated varicella vaccine + live attenuated Japanese encephalitis vaccine

Development stage
Unknown
Lead developer
Merck
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

This is a combination of two live attenuated vaccines administered together for the prevention of varicella (chickenpox) and Japanese encephalitis (JE). The live attenuated varicella vaccine contains an Oka strain of varicella-zoster virus, which induces immunity by mimicking natural infection and stimulating both humoral and cellular immune responses[1][5]. The live attenuated JE vaccine (such as JE-CV or SA14-14-2) uses a weakened form of the Japanese encephalitis virus to elicit protective neutralizing antibodies against JE[6][8]. Both vaccines are primarily indicated for children in endemic regions or travelers at risk. Co-administration has been shown to be safe and immunogenic, with no significant reduction in efficacy or increase in adverse events compared to separate administration[6][8].

Other names
Live Attenuated Varicella Vaccine + Live Attenuated JE VaccineVaricella and JE Vaccine Co-administration

Beyond the preview

Go deeper on live attenuated varicella vaccine + live attenuated Japanese encephalitis vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on live attenuated varicella vaccine + live attenuated Japanese encephalitis vaccine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call